Desktop Site
|
28 Mar 24 | 16:00
|
Close
Equity
SME
Eq Drv
Currency
Commodity
Corporates
Get Quote
Notices
|
S&P
BSE SENSEX
73,651.35
+655.04
+0.90 %
Corporate Announcement
Security Code
500124
Company
Dr Reddys Laboratories Ltd
Exchange Received Time
17/05/2017 12:40:58
Exchange Disseminated Time
17/05/2017 12:41:04
Time Taken
00:00:06
Updates |
5/17/2017 12:40:59 PM
Please find enclosed a Press Release on 'Dr. Reddy's Laboratories announces USFDA approval for the launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market'. This is for your information.
Attachment
<< Back
Recently Viewed